Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 50

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 5
Chunk 50
---
 of convertible or equity financing to improve our liquidity and capital resource
needs. However, there is no assurance that management will be successful in our financing plans. Should we need to seek additional capital
prior to the closing of any financing transaction, we may continue to go to our related parties for additional financial support. We
can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to us,
if at all. If one or all of these events does not occur or subsequent capital raises are insufficient to bridge financial and liquidity
shortfall, there would likely be a material adverse effect on us and would materially adversely affect our ability to continue as a going
concern.

  33  

Discontinued
operations may entail contingent liabilities, such as legal claims, tax clearance and etc. The resolution of these liabilities could
require cash outflows, impacting the Company’s liquidity and financial flexibility. If proceeds from discontinued operations are
used to repay debt obligations, the Company’s liquidity may improve in the long term by reducing interest expenses and debt service
requirements. However, the immediate impact on liquidity will depend on the timing and amount of debt repayment.

The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of business and, as such, the financial statements do not include any adjustments
relating to the recoverability and classification of recorded amounts or amounts and classification of liabilities that might be necessary
should we be unable to continue in existence.

The
following table provides summary information about our net cash flow for financial statement periods presented in this report:

                                                                                        For the Years Ended December 31,                                                                      
                                                                                        2024                                                  2023                      2022                  
  Net cash used in operating activities from continuing operations                      $                                     (2,025,572      $         (3,213,862      $            (87,800  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Net cash (used in) provided by operating activities from discontinued operations                                                (9,155                   295,967                (1,439,028  
  Net cash used in investing activities from continuing operations                                                              (144,618                         -                  (246,664  
  Net cash used in investing activities from discontinued operations                                                              (3,148                         -                   (21,542  
  Net cash provided by financing